Facial Edema Reduction by Manual Lymphatic Drainage at Postoperative Alveolar Bone Grafting

Phase 1

Conditions: Facial swelling after alveolar bone grafting.
C05.500.460.185

Registration Number: RBR-4z7cnh

Lead Sponsor: Hospital de Reabilitação de Anomalias Craniofaciais/ USP

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruitment completed

Sex: Not specified

Target Recruitment: Not specified

Inclusion Criteria

Cleft lip and palate.

Exclusion Criteria

Hypertension.

Study & Design

Study Type: Intervention

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method

Secondary Outcome Measures

Name	Time	Method

Related Trials

Effect of COVI Soup on BMI, Immunological and Haematological Parameters Among People Living With HIV in Kakamega County Kenya

Not Applicable

Masinde Muliro University of Science and Tachnology

Updated 3/4/2024

Management of Lymphatic Filariasis with Homeopathic Medicines.

Phase 2

Central Council for Research in Homoeopathy

Updated 11/24/2021

Randomized parallel controlled trial of "on demand" therapy versus continuous therapy of omepral 20mg in effectiveness and safety for the patients {Los Angeles classification grade M (LA M) or more)} diagnosed as the gastroesophageal reflux disease.

Not Applicable

Department of Gastroenterology Juntendo University School of Medicine

Updated 10/17/2023

An Open-labelled, Randomized, Parallel Group Trial of zalutumumab, a Human Monoclonal Anti-EGF receptor Antibody, in combination with Best Supportive Care, versus Best Supportive Care, in Patients with Non-Curable Squamous Cell Carcinoma of the Head and Neck who have failed standard platinum-based chemotherapy. - zalutumumab in non-curable patients with SCCH

Genmab A/S

Updated 4/3/2012

Open-label, randomized parallel group trial on the efficacy and safety of intra-articular administration of bevacizumab for knee osteoarthritis.

RecruitingNot Applicable

ational Hospital Organization Sagamihara Hospital

Updated 10/17/2023

An Open-labeled, Randomized, Parallel Group Trial of zalutumumab, a Human Monoclonal Anti-EGF receptor Antibody, in combination with Best Supportive Care, versus Best Supportive Care, in Patients with Non-Curable Squamous Cell Carcinoma of the Head and Neck who have failed standard platinum-based chemotherapy. - zalutumumab in non-curable patients with SCCH

Phase 1

Genmab A/S

Updated 7/27/2020

An Open-labeled, Randomized, Parallel Group Trial of zalutumumab, a Human Monoclonal Anti-EGF receptor Antibody, in combination with Best Supportive Care, versus Best Supportive Care, in Patients with Non-Curable Squamous Cell Carcinoma of the Head and Neck who have failed standard platinum-based chemotherapy.

Phase 1

Genmab A/S

Updated 8/8/2022

An Open-labeled, Randomized, Parallel Group Trial of zalutumumab, a Human Monoclonal Anti-EGF receptor Antibody, in combination with Best Supportive Care, versus Best Supportive Care, in Patients with Non-Curable Squamous Cell Carcinoma of the Head and Neck who have failed standard platinum-based chemotherapy. - zalutumumab in non-curable patients with SCCH

Genmab A/S

Updated 4/3/2012

An Open-labeled, Randomized, Parallel Group Trial of zalutumumab, a Human Monoclonal Anti-EGF receptor Antibody, in combination with Best Supportive Care, versus Best Supportive Care, in Patients with Non-Curable Squamous Cell Carcinoma of the Head and Neck who have failed standard platinum-based chemotherapy.Ensayo abierto, aleatorizado, de grupos paralelos con zalutumumab , un anticuerpo monoclonal humano anti-receptor de EGF, en combinación con los mejores cuidados de soporte, frente a los mejores cuidados de soporte solamente, en pacientes con carcinoma escamoso de cabeza y cuello incurable que no han respondido a la quimioterapia estándar basada en platino. - zalutumumab in non-curable patients with SCCH

Phase 1

Genmab A/S

Updated 8/8/2022

An Open-labeled, Randomized, Parallel Group Trial of zalutumumab, a Human Monoclonal Anti-EGF receptor Antibody, in combination with Best Supportive Care, versus Best Supportive Care, in Patients with Non-Curable Squamous Cell Carcinoma of the Head and Neck who have failed standard platinum-based chemotherapy. - zalutumumab in non-curable patients with SCCH

Genmab A/S

Updated 4/3/2012

Clinical Trial Alerts

Stay informed of key developments in this trial with timely notifications for researchers and healthcare professionals.

Enrollment status and site changes

Protocol modifications and amendments

Outcome data and publication updates

Clinical Trial Alerts

Stay informed of key developments in this trial with timely notifications for researchers and healthcare professionals.

Enrollment status and site changes

Protocol modifications and amendments

Outcome data and publication updates

Home Terms & Conditions Privacy Policy

Facial Edema Reduction by Manual Lymphatic Drainage at Postoperative Alveolar Bone Grafting

Recruitment & Eligibility

Study & Design

Related Trials

Effect of COVI Soup on BMI, Immunological and Haematological Parameters Among People Living With HIV in Kakamega County Kenya

Management of Lymphatic Filariasis with Homeopathic Medicines.

Randomized parallel controlled trial of &quot;on demand&quot; therapy versus continuous therapy of omepral 20mg in effectiveness and safety for the patients {Los Angeles classification grade M (LA M) or more)} diagnosed as the gastroesophageal reflux disease.

Open-label, randomized parallel group trial on the efficacy and safety of intra-articular administration of bevacizumab for knee osteoarthritis.

Clinical Trial Alerts

Clinical Trial Alerts

Randomized parallel controlled trial of "on demand" therapy versus continuous therapy of omepral 20mg in effectiveness and safety for the patients {Los Angeles classification grade M (LA M) or more)} diagnosed as the gastroesophageal reflux disease.